Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Security class unavailable · CUSIP: 68277Q105
Event date: 2024-10-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-108113
- Form type
- SC 13G
- Filer
- CITADEL ADVISORS LLC
- CIK
- CIK 1423053
- Filed
- Oct 11, 2024
- Reporting period
- Oct 04, 2024
- Description
- Schedule 13G beneficial ownership